Please assess the completion status of the following clinical trial:

Trial Title: Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Postmenopausal~* BMD T-score \<-2.5sd~Exclusion Criteria:~* None

- Gender: FEMALE
- Minimum Age: 50 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Clodronate 800 mg / day + estradiol 2 mg + norethisterone acetate 1 mg / day for five years.
- 2 (Type: PLACEBO_COMPARATOR): Placebo 2 tablets/ day + estradiol 2 mg + norethisterone acetate 1 mg / day for five years.
- 3 (Type: ACTIVE_COMPARATOR): Clodronate 800 mg / day for five years.

Based on this trial design, predict the completion outcome and termination type (if applicable).